WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004004827) PACEMAKER EVALUATION METHOD AND APPARATUS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/004827    International Application No.:    PCT/AU2003/000807
Publication Date: 15.01.2004 International Filing Date: 26.06.2003
IPC:
A61B 8/06 (2006.01), A61N 1/37 (2006.01), A61N 1/372 (2006.01)
Applicants: USCOM PTY LTD [AU/AU]; 323 Old Coast Road, Korora, New South Wales 2450 (AU) (For All Designated States Except US).
PHILLIPS, Robert, Allan [AU/AU]; (AU) (For US Only)
Inventors: PHILLIPS, Robert, Allan; (AU)
Agent: SHELSTON IP; 60 Margaret Street, Sydney NSW 2000 (AU)
Priority Data:
PS 3355 03.07.2002 AU
Title (EN) PACEMAKER EVALUATION METHOD AND APPARATUS
(FR) PROCEDE ET APPAREIL D'EVALUATION D'UN STIMULATEUR CARDIAQUE
Abstract: front page image
(EN)A method of optimizing the performance of a cardiac prosthetic pacing device including monitoring, optionally transcutaneously or non-invasively, the flow output from the heart; optionally using a continuous wave Doppler ultrasound device, followed by adjusting the timing of said cardiac prosthetic pacing device so as to optimize the flow from the heart under operational condition, optionally including different pharmacological conditions.
(FR)L'invention concerne un procédé permettant d'optimiser les performances d'un dispositif stimulateur prothétique cardiaque, procédé consistant à contrôler, éventuellement par voie transcutanée ou non invasive, le débit sanguin à la sortie du coeur, le cas échéant au moyen d'un dispositif ultrasonique Doppler à onde entretenue, puis à ajuster le rythme dudit dispositif stimulateur prothétique cardiaque, de manière à optimiser le débit sanguin à la sortie du coeur, dans des conditions opérationnelles, y compris, le cas échéant, des conditions pharmacologiques différentes.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)